Federated Hermes’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Federated Hermes’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,694	Closed	-$127K	–	2266
2016 Q3	$127K	Buy	25,694 +4	+0%	+$20	﹤0.01%	1537
2016 Q2	$131K	Buy	25,690 +7,652	+42%	+$41.2K	﹤0.01%	1530
2016 Q1	$103K	Buy	+18,038	New	+$126K	﹤0.01%	1564
2015 Q3	–	Sell	-3,472	Closed	-$68K	–	2146
2015 Q2	$68K	Buy	+3,472	New	+$61.4K	﹤0.01%	1618
2013 Q4	–	Sell	-2,656	Closed	-$44K	–	1859
2013 Q3	$44K	Buy	+2,656	New	+$39.3K	﹤0.01%	1636

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's OSIR Position: Q4 2016 in Review

Federated Hermes sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2016, closing a stake of 25,694 shares — an estimated $127K sold.

Federated Hermes first reported a position in OSIR in Q3 2013 and held it in 5 quarters. The position peaked at $131K in Q2 2016. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

Federated Hermes reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Federated Hermes sold 25,694 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $127K.
Federated Hermes first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
Federated Hermes's Osiris Therapeutics, Inc. Common Stock position peaked at $131K in Q2 2016.
64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Federated Hermes's 13F filing for Q4 2016, filed 10 Feb 2017.